(0.15%) 5 162.25 points
(0.15%) 38 891 points
(0.11%) 18 021 points
(0.78%) $78.72
(0.56%) $2.15
(0.62%) $2 322.80
(2.24%) $27.29
(0.18%) $967.00
(0.05%) $0.929
(-0.10%) $10.86
(-0.10%) $0.796
(0.16%) $91.60
4 days till quarter result
(bmo 2024-05-10)
Expected move: +/- 0.00%
-1.59% SEK 372.00
Live Chart Being Loaded With Signals
Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific...
Stats | |
---|---|
Dzisiejszy wolumen | 1 379.00 |
Średni wolumen | 65 328.00 |
Kapitalizacja rynkowa | 11.72B |
EPS | SEK0 ( 2024-04-23 ) |
Następna data zysków | ( SEK0.310 ) 2024-05-10 |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | 111.71 |
ATR14 | SEK0.701 (0.19%) |
Wolumen Korelacja
Xvivo Perfusion AB (publ) Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Xvivo Perfusion AB (publ) Korelacja - Waluta/Towar
Xvivo Perfusion AB (publ) Finanse
Annual | 2023 |
Przychody: | SEK597.54M |
Zysk brutto: | SEK416.91M (69.77 %) |
EPS: | SEK3.07 |
FY | 2023 |
Przychody: | SEK597.54M |
Zysk brutto: | SEK416.91M (69.77 %) |
EPS: | SEK3.07 |
FY | 2022 |
Przychody: | SEK415.29M |
Zysk brutto: | SEK296.96M (71.51 %) |
EPS: | SEK0.620 |
FY | 2021 |
Przychody: | SEK258.39M |
Zysk brutto: | SEK188.28M (72.87 %) |
EPS: | SEK0.0777 |
Financial Reports:
No articles found.
Xvivo Perfusion AB (publ)
Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers XVIVO System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XVIVO Silicone Tubing Set for rapid flushing of donor lungs during procurement; and XVIVO LS and XVIVO Disposable Lung Set, a device for EVLP. In addition, the company offers XVIVO Organ Chamber, a single-use sterile disposable container intended to be used as a temporary receptacle for isolated lungs in preparation for eventual transplantation into a recipient; and XVIVO Lung Cannula Set, a single-use, sterile disposable product. The company was incorporated in 1998 and is headquartered in Gothenburg, Sweden.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej